Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 6,604 | 6,701 | 5,770 | 5,456 | 5,293 |
| Cost of Goods | 2,094 | 1,968 | 1,647 | 1,710 | 1,606 |
| Gross Profit | 4,510 | 4,733 | 4,123 | 3,746 | 3,687 |
| Operating Expenses | 5,376 | 4,954 | 4,204 | 3,414 | 3,098 |
| Operating Income | -772 | 747 | 566 | 1,042 | 1,195 |
| Interest Expense | 1 | 1 | 3 | 2 | 1 |
| Other Income | 11,042 | 3,506 | -19,724 | -28,418 | 37 |
| Pre-tax Income | 10,269 | 4,252 | -19,161 | -27,378 | 1,231 |
| Net Income Continuous | 10,269 | 4,252 | -19,161 | -27,378 | 1,231 |
| Net Income | $10,269 | $4,252 | $-19,161 | $-27,378 | $1,231 |
| EPS Basic Total Ops | 0.42 | 0.18 | -1.03 | -1.69 | 0.07 |
| EPS Basic Continuous Ops | 0.52 | 0.23 | -1.03 | -1.68 | 0.07 |
| EPS Diluted Total Ops | 0.35 | 0.02 | -1.03 | -1.65 | 0.05 |
| EPS Diluted Continuous Ops | 0.41 | 0.17 | -1.03 | -1.65 | 0.05 |
| EBITDA(a) | $-247 | $962 | $664 | $1,230 | $1,247 |